Insider Transactions in Q2 2023 at Enfusion, Inc. (ENFN)
Insider Transaction List (Q2 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 26
2023
|
Lawrence E Leibowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,233
+9.86%
|
-
|
Jun 26
2023
|
Kathleen De Rose Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,233
+24.38%
|
-
|
Jun 26
2023
|
Jan Hauser Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,233
+25.52%
|
-
|
Jun 26
2023
|
Michael Spellacy Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,233
+26.01%
|
-
|
Jun 26
2023
|
Deirdre Somers Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,233
+29.59%
|
-
|
Jun 20
2023
|
Dan Groman Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
3,877
-3.33%
|
$31,016
$8.86 P/Share
|
Jun 15
2023
|
Deirdre Somers Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,154
-6.98%
|
$25,232
$8.87 P/Share
|
Jun 15
2023
|
Dan Groman Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,505
-7.22%
|
$156,040
$8.87 P/Share
|
Jun 15
2023
|
Dan Groman Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
44,260
+24.54%
|
-
|
Jun 15
2023
|
Lawrence E Leibowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,578
+10.52%
|
-
|
Jun 15
2023
|
Bronwen Bastone Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,810
-3.24%
|
$86,480
$8.87 P/Share
|
Jun 15
2023
|
Bronwen Bastone Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,285
+0.76%
|
-
|
Jun 15
2023
|
Bradford E Bernstein Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,142,857
+3.4%
|
$9,142,856
$8.12 P/Share
|
May 24
2023
|
Bronwen Bastone Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,112
-0.67%
|
$7,784
$7.93 P/Share
|
May 24
2023
|
Bronwen Bastone Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,298
+1.94%
|
-
|
May 24
2023
|
Dan Groman Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
47,630
-34.15%
|
$333,410
$7.93 P/Share
|
May 24
2023
|
Dan Groman Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
113,538
+44.88%
|
-
|
May 24
2023
|
Lawrence E Leibowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,396
+25.46%
|
-
|
May 22
2023
|
Dan Groman Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
53,877
-35.35%
|
$377,139
$7.96 P/Share
|
May 10
2023
|
Dan Groman Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
15,048
-15.86%
|
$120,384
$8.34 P/Share
|
Apr 25
2023
|
Bronwen Bastone Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
216
-0.13%
|
$1,728
$8.33 P/Share
|
Apr 25
2023
|
Bronwen Bastone Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
638
+0.39%
|
-
|
Apr 25
2023
|
Lawrence E Leibowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,238
+9.13%
|
-
|
Apr 25
2023
|
Dan Groman Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,219
-8.86%
|
$73,752
$8.33 P/Share
|
Apr 25
2023
|
Dan Groman Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,974
+17.43%
|
-
|
Apr 17
2023
|
Dan Groman Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
3,877
-4.51%
|
$34,893
$9.66 P/Share
|